Global Immunoglobulin Therapeutics Market


USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

Immunoglobulin (Ig) therapies are among the oldest therapeutic moieties employed in a broad range of pathological conditions. Immunoglobulin G (IgG) holds the highest share (44%) in the global blood plasma market, with a revenue of $9.24 billion. Currently, the global Ig market is dominated by three major companies, holding about 85% of the total market share. The growing incidence of epidemic outbreaks caused by pathogens has positioned Ig therapy as a primary area of focus in meeting future healthcare demands. With an ever increasing demand for Ig products, companies are looking for novel advances in drug delivery technologies and manufacturing processes to survive and succeed in this competitive landscape.

Table of Contents

Global Immunoglobulin Therapeutics MarketImmunoglobulin Therapeutics MarketGlobal Immunoglobulin Therapeutics Market

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.